On ECHEMI
Home > Drugs > Henan Yonghe Pharmaceutical Co., Ltd.
Henan Yonghe Pharmaceutical Co., Ltd.
  • Founded in:

    1997-09-10
  • Country:

    China China
  • Address:

    No. 28, Yinping Road, Zhengzhou High-tech Development Zone
  • Tax NO.:

    91410100268054747H
  • Registered Funds:

    35 million yuan
  • Email:

Related Drugs
Tinidazole Sodium Chloride Injection
tinidazole
Name Description Content CAS NO. Registered Holders
Tinidazole

It has high activity against protozoa and anaerobic bacteria. It has antibacterial activity against Bacteroides fragilis and other Bacteroides, Fusobacterium, Clostridium, Peptococcus, Peptostreptococcus, Veillonella and Gardnerella. A concentration of 2-4 mg/L can inhibit most anaerobic bacteria; microaerophilic bacteria and Helicobacter pylori are sensitive to it; the MIC for Trichomonas vaginalis is similar to that of metronidazole, and its metabolites are more active against Gardnerella than metronidazole. The mechanism of action is to inhibit the bacterial DNA metabolism process and the redox reaction of amoeba, resulting in the breakage of nitrogen chains, thereby killing bacteria and protozoa. Resistant bacteria often lack nitroreductase and are resistant to this product.

More

It has high activity against protozoa and anaerobic bacteria. It has antibacterial activity against Bacteroides fragilis and other Bacteroides, Fusobacterium, Clostridium, Peptococcus, Peptostreptococcus, Veillonella and Gardnerella. A concentration of 2-4 mg/L can inhibit most anaerobic bacteria; microaerophilic bacteria and Helicobacter pylori are sensitive to it; the MIC for Trichomonas vaginalis is similar to that of metronidazole, and its metabolites are more active against Gardnerella than metronidazole. The mechanism of action is to inhibit the bacterial DNA metabolism process and the redox reaction of amoeba, resulting in the breakage of nitrogen chains, thereby killing bacteria and protozoa. Resistant bacteria often lack nitroreductase and are resistant to this product.

19387-91-8 14
Fenbufen Capsules
The main ingredient of this product is fenbufen. Its chemical name is 3-(4-biphenylcarbonyl) propionic acid. Molecular formula: C16H14O3 Molecular weight: 254.28
Name Description Content CAS NO. Registered Holders
Fenbufen

This product is a long-acting non-steroidal anti-inflammatory drug. After entering the body, it is metabolized into diphenyl ethyl ester, which inhibits the activity of cyclooxygenase and reduces the synthesis of prostaglandins. Animal experiments show that the anti-inflammatory and analgesic effects of this product are weaker than indomethacin, but stronger than aspirin.

More

This product is a long-acting non-steroidal anti-inflammatory drug. After entering the body, it is metabolized into diphenyl ethyl ester, which inhibits the activity of cyclooxygenase and reduces the synthesis of prostaglandins. Animal experiments show that the anti-inflammatory and analgesic effects of this product are weaker than indomethacin, but stronger than aspirin.

36330-85-5 9
Domiphene lozenges
This product is a compound preparation, the main ingredient of which is domiphene. Each tablet contains 0.5 mg of domiphene, and the auxiliary ingredients are sucrose, dextrin, sunset yellow, menthol, and talcum powder.
Name Description Content CAS NO. Registered Holders
Domiphen bromide

This product is a cationic surfactant with broad-spectrum bactericidal effect

More

This product is a cationic surfactant with broad-spectrum bactericidal effect

0.5mg 0
Sucrose

This product is a cationic surfactant with broad-spectrum bactericidal effect.

More

This product is a cationic surfactant with broad-spectrum bactericidal effect.

57-50-1 73
Dextrin

This product is a cationic surfactant with broad-spectrum bactericidal effect.

More

This product is a cationic surfactant with broad-spectrum bactericidal effect.

9004-53-9 49
Sunset Yellow FCF

This product is a cationic surfactant with broad-spectrum bactericidal effect.

More

This product is a cationic surfactant with broad-spectrum bactericidal effect.

2783-94-0 1
DL-Menthol

This product is a cationic surfactant with broad-spectrum bactericidal effect.

More

This product is a cationic surfactant with broad-spectrum bactericidal effect.

89-78-1 8
Talc

This product is a cationic surfactant with broad-spectrum bactericidal effect.

More

This product is a cationic surfactant with broad-spectrum bactericidal effect.

14807-96-6 27
Afencamin Tablets
This product is a compound preparation, each tablet contains 230 mg of aspirin, 126 mg of acetaminophen, 30 mg of caffeine, and 1 mg of chlorpheniramine maleate. The excipients are:
Name Description Content CAS NO. Registered Holders
Acetylsalicylic acid

Inhibits prostaglandin synthesis and has antipyretic and analgesic effects

More

Inhibits prostaglandin synthesis and has antipyretic and analgesic effects

230mg 50-78-2 35
Acetaminophen

Inhibits prostaglandin synthesis and has antipyretic and analgesic effects

More

Inhibits prostaglandin synthesis and has antipyretic and analgesic effects

126mg 103-90-2 68
Caffeine

Central nervous system stimulants that can enhance the antipyretic and analgesic effects of the above drugs

More

Central nervous system stimulants that can enhance the antipyretic and analgesic effects of the above drugs

30mg 0
Chlorphenamine maleate

Antihistamines, which can relieve runny nose and sneezing caused by colds

More

Antihistamines, which can relieve runny nose and sneezing caused by colds

1mg 113-92-8 28
Dextran 20 Glucose Injection
Main ingredients: This product is a sterile aqueous solution of dextran 20 and glucose. Dextran 20 is a small molecule glucose polymer generated by fermentation of sucrose, with an average molecular weight of 20,000.
Name Description Content CAS NO. Registered Holders
Dextran 20

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water into the systemic circulation to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect. This product has strong antigenicity.

More

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water into the systemic circulation to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect. This product has strong antigenicity.

0
GLUCOSE

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water into the systemic circulation to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate already aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect. This product has strong antigenicity. Since there are bacteria that produce this product in the normal intestine, some patients will have allergic reactions even after the first injection of this product. Mainly skin and mucous membrane allergic reactions.

More

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water into the systemic circulation to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate already aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect. This product has strong antigenicity. Since there are bacteria that produce this product in the normal intestine, some patients will have allergic reactions even after the first injection of this product. Mainly skin and mucous membrane allergic reactions.

58367-01-4 15
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.